The global Human Immunodeficiency Virus (HIV) Drugs market garnered revenue around USD XX Billion in 2019 and projected to reach USD 33.9 Million in 2027, with at a compound annual growth rate of 5.3% throughout the estimate period from 2020 to 2027.
Human immunodeficiency virus (HIV) spreads through body fluids, such as blood and seminal fluid, and attacks the human immune system, especially CD4 cells (often called T cells). The weakening of the immune system results in the occurrence of opportunistic infections and results in acquired immunodeficiency syndrome (AIDS).
Increasing prevalence of HIV infection The number of individuals diagnosed with HIV has grown exponentially over the years. For instance, in 2018, the number of individuals infected by HIV worldwide was reportedly 1.7 million.
HIV infection cannot be cured completely. Hence, administering HIV drugs is necessary for controlling its spread and progression to AIDS.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Human Immunodeficiency Virus (HIV) Drugs market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Human Immunodeficiency Virus (HIV) Drugs market growth.
The global Human Immunodeficiency Virus (HIV) Drugs market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Boehringer Ingelheim International GmbH (Germany)
Cipla Inc. (India)
Merck & Co., Inc. (US)
AbbVie Inc. (US)
Bristol-Myers Squibb Company (US)
Teva Pharmaceutical Industries Ltd (Israel)
Gilead Sciences, Inc. (US)
Hoffmann-La Roche Ltd (Switzerland)
Pfizer Inc. (US)
Aurobindo Pharma (India)
Celltrion Healthcare Co., Ltd (South Korea)
ViiV Healthcare (UK)
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
By Type
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs):
Protease Inhibitors (PIs):
Integrase Inhibitors:
Fusion Inhibitors:
CCR5 Antagonist
Post-Attachment Inhibitor or Monoclonal Antibody:
By End-User
Hospitals & Clinics:
Specialty Centers:
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
North America
? U.S.
? Canada
Europe
? Germany
? U.K.
? Italy
? France
? Rest of EU
Asia Pacific
? China
? India
? Japan
? Southeast Asia
? Rest of APAC
Central & South America
? Brazil
? Argentina
? Rest of Central & South America
Middle East and Africa
? UAE
? Saudi Arabia
? Rest of MEA
Request Customization
Get a Sample
Get a Sample
Request Customization